EFFICACY AND SAFETY OF IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO TNF INHIBITORS: THREE YEAR RESULTS FROM A PHASE 3 STUDY (SPIRIT-P2)

被引：0
|
作者：
Gratacos-Masmitja, J. [1 ]
Turkiewicz, A. [2 ]
Dokoupilova, E. [3 ,4 ]
Gellett, A. M. [5 ]
Sprabery, T. [5 ]
Geneus, V. J. [5 ]
Constantin, A. [6 ]
机构：
[1] Univ Hosp Parc Tauli Sabadell, Barcelona, Spain
[2] Rheumatol Associates PC, Birmingham, AL USA
[3] Med Plus Sro, Uherske Hradiste, Czech Republic
[4] Univ Vet & Pharmaceut Sci, Dept Pharmaceut, Fac Pharm, Brno, Czech Republic
[5] Eli Lilly & Co, Indianapolis, IN 46285 USA
[6] Hosp Pierre Paul Riquet, Toulouse, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.1482
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0411
引用
收藏
页码：1154 / 1154
页数：1
相关论文
共 50 条
  • [41] SAFETY OF IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A POOLED ANALYSIS OF THREE CLINICAL TRIALS
    Goupille, P.
    Roussou, E.
    Burmester, G.
    Mease, P. J.
    Gottlieb, A. B.
    Garces, S.
    Benichou, O.
    Adams, D.
    Xu, W.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1039 - 1040
  • [42] Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials
    Mease, Philip
    Roussou, Euthalia
    Burmester, Gerd-Ruediger
    Goupille, Philippe
    Gottlieb, Alice
    Moriarty, Susan R.
    Benichou, Olivier
    Adams, David H.
    Xu, Wen
    Nash, Peter
    ARTHRITIS CARE & RESEARCH, 2019, 71 (03) : 367 - 378
  • [43] EFFICACY AND SAFETY OF IXEKIZUMAB AT WEEK 52 IN BIOLOGIC NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS (SPIRIT-P1)
    Lespessailles, Eric
    Kirkham, Bruce
    Nebro, Antonio Fernandez
    Blanco, Ricardo
    Strehblow, Christoph
    Inciarte-Mundo, Jose
    Porsdal, Vibeke
    Garcia, Miriam
    Kurzawa, Monika
    Sapin, Christophe
    Geusens, Piet
    Goupille, Philippe
    Tahir, Hasan
    RHEUMATOLOGY, 2018, 57
  • [44] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    McInnes, Iain B.
    Kato, Koji
    Magrey, Marina
    Merola, Joseph F.
    Kishimoto, Mitsumasa
    Haaland, Derek
    Chen, Liang
    Duan, Yuanyuan
    Liu, Jianzhong
    Lippe, Ralph
    Wung, Peter
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 275 - 292
  • [45] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    Iain B. McInnes
    Koji Kato
    Marina Magrey
    Joseph F. Merola
    Mitsumasa Kishimoto
    Derek Haaland
    Liang Chen
    Yuanyuan Duan
    Jianzhong Liu
    Ralph Lippe
    Peter Wung
    Rheumatology and Therapy, 2023, 10 : 275 - 292
  • [46] Integrated Efficacy Results from Two Phase 3 Trials of Ixekizumab for the Treatment of Psoriatic Arthritis
    Combe, Bernard
    Nash, Peter
    Adams, David
    Kerr, Lisa
    Benichou, Olivier
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] Ixekizumab treatment of biologic-naive patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)
    Chandran, Vinod
    van der Heijde, Desiree
    Fleischmann, Roy M.
    Lespessailles, Eric
    Helliwell, Philip S.
    Kameda, Hideto
    Burgos-Vargas, Ruben
    Erickson, Janelle S.
    Rathmann, Suchitrita S.
    Sprabery, Aubrey Trevelin
    Birt, Julie A.
    Shuler, Catherine L.
    Gallo, Gaia
    RHEUMATOLOGY, 2020, 59 (10) : 2774 - 2784
  • [48] EFFICACY OF IXEKIZUMAB IMPROVING SF-36 SCORES IN BIOLOGIC DMARD-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 STUDY (SPIRIT-P1)
    Strand, V.
    Gottlieb, A. B.
    Kvien, T. K.
    Naegeli, A.
    Lin, C-Y.
    Benichou, O.
    Birt, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1334 - 1335
  • [49] Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naive Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study
    Smolen, Josef S.
    Sebba, Anthony
    Ruderman, Eric M.
    Schulze-Koops, Hendrik
    Sapin, Christophe
    Gellett, Amanda M.
    Sprabery, Aubrey Trevelin
    Li, Lingnan
    de la Torre, Inmaculada
    Gallo, Gaia
    Liu-Leage, Soyi
    Pillai, Sreekumar
    Reis, Paulo
    Nash, Peter
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 1021 - 1035
  • [50] Efficacy and safety of ixekizumab at week 52 in biologic-naive patients with active psoriatic arthritis (SPIRIT-P1)
    Lespessailles, E.
    Kirkham, B.
    Nebro, A.
    Alonso, R.
    Strehblow, C.
    Inciarte, J.
    Porsdal, V.
    Garcia, M.
    Kurzawa, M.
    Sapin, C.
    Geusens, P.
    Goupille, P.
    Tahir, H.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 44 - 45
12345